At 8:30 a.m., 125 or so researchers crowded into the CSU Spur. Some were toting their posters. Some were clutching their coffee and laptops. They settled in to learn about the links between plastic exposure and chronic disease risk; they heard about a novel cancer treatment tested in both golden retrievers and humans; and they listened to researchers discuss advances in cartilage regeneration. What connected these wide-ranging topics? It was the CCTSI’s CU-CSU Summit conference on chronic disease research.
Dr. Pochih Shen, research fellow in the group, presented his study titled “3D-Printed Growth Plate Mimetic Composite Mitigates Early Growth Deformities in a Rabbit Model.” His talk was followed by Dr. Ana Ferreira Ruble, who shared her latest work on “Optimization of a 3D-Printed Growth Plate Mimetic Composite for the Treatment of Growth Plate Injuries.”
Osteoarthritis, a painful degenerative disease that affects 32.5 million Americans, slowly degrades buffering cartilage until joints grind together bone-on-bone. With no existing effective regenerative therapy, treatments are limited to anti-inflammatory injections and, ultimately, expensive joint replacement surgery.
Imagine a day when joints could heal themselves.
At the first inkling of a creaky knee, patients could get a single shot in the joint that would not only stop their cartilage and bone from eroding, but kick-start its regrowth. In more advanced cases, that shot might also deliver a biomaterial repair kit to patch holes in tissue. If multiple joints ached, an annual IV infusion could ferry regenerating therapies to all of them at once.